Public Comment

Public Comment is a vital part of our multistakeholder model. It provides a mechanism for stakeholders to have their opinions and recommendations formally and publicly documented. It is an opportunity for the ICANN community to effect change and improve policies and operations.

Contenido disponible solo en los siguientes idiomas

  • English

Summary of Submission

I OPPOSE, REJECT, DISAPPROVE, & OBJECT TO this Initial Report from the EPDP on Specific Curative Rights Protections for IGOs. This is no different than an attempt to open the flood gates of allowing people to perform reverse domain name hijacking on any & all domains without any consequences whatsoever. Domain names are essentially no different than luxury goods. Domain names have never been the determining factor of whether an IGO or any company can exist, thrive, be recognized by the general public, continue to be in operation, continually function, and/or succeed. For example, WHO.int never needed WHO.com in order to exist. The general public can easily find out that WHO.int is the correct domain name for the IGO known as WHO. This report is attempting to infringe the rights of every legitimate business owner who uses short acronyms in their domain names by allowing currently existing and future IGOs to take away any and all domain names from every legitimate business owner. This report is also tantamount to disrespecting the peoples' rights to due process & legal equality by allowing privileged groups such as IGOs to bypass the Court for unnecessary disputes such as domain name disputes on domain names that the IGOs never needed in order to continually function.


This report is an unnecessary report that is self-serving and nothing more than a desire to fulfil the greed of only and only the super rich, privileged, and powerful people such as the IGOs who wanted more than is needed to operate their organizations.


To conclude, I will repeat my initial stand that I OPPOSE, REJECT, DISAPPROVE, & OBJECT TO this Initial Report from the EPDP on Specific Curative Rights Protections for IGOs.